activated CIK armed with bispecific antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for activated CIK armed with bispecific antibody, covering 2021-02-01 to 2021-02-01. Get the full timeline:
Most recent: Clinical Trial Update: Study of Activated CIK Armed With Bispecific Antibody for Advanced Liver Cancer [Phase 2]